Midregional pro-adrenomedullin (MR-proADM), an indicator of hypoxia, is relevant in the context of APE and is involved in increased vascular permeability in both heart failure and severe hypoxia [16–18]. The gene discussed is ADM; the disease is apparent mineralocorticoid excess.